Previous Chapter: 5 Overarching Conclusions
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.

Appendix A

Public Meeting Agendas

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Tuesday, November 19, 2024 (12:30–1:30 PM ET)
SESSION 1—OPEN

12:30–12:40 Welcome and Introductions
Paul Volberding, Committee Chair

Vince Nibali, Technical Expert, Office of Medical Policy, Social Security Administration (SSA)

12:40–1:00 Social Security Administration Overview

Vince Nibali, Technical Expert, Office of Medical Policy, Social Security Administration

1:00–1:30 Questions and Discussion
Jennifer Koop, Committee Vice Chair, moderator
Committee Members and SSA Staff
1:30 Adjourn Public Session
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Friday, December 20, 2024 (1:00–4:00 PM ET)
WEBINAR 1: Hospitalization and Sickle Cell Disease (SCD)

1:00–1:10 Welcome Remarks and Introductions
Paul Volberding, Committee Chair
Jennifer Koop, Committee Vice Chair
1:10–1:30 Sponsor Remarks, Social Security Administration

Michael Goldstein, Director of the Office of Medical Policy, Social Security Administration

Andrea Bento, Technical Expert in the Office of Medical Policy, Social Security Administration

1:30–2:30 Session I: Living with SCD
Moderators
Coretta Jenerette, Committee Member
Marilyn Baffoe-Bonnie, Committee Member
Panelists

Tristan Lee, Professional model, actor, fashion designer, and patient advocate for SCD; SCD Warrior

Christelle Salomon, Health Policy and Education Analyst, University of California, San Francisco Benioff Children’s Hospitals; SCD Warrior

Sharee Turpin, Patient Navigator, University of Rochester Medicine; SCD Warrior

Nikia K. Vaughan, Executive Director, Maryland Sickle Cell Disease Association; SCD Caregiver

Teonna Woolford, CEO, Sickle Cell Reproductive Health Education Directive; SCD Warrior

Q & A with Panelists
2:30–2:45 Break
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
2:45–3:45 Session II: Hospitalization in SCD
Moderators
Jeffrey Glassberg, Committee Member
Ashley Jenkins, Committee Member
Panelists

Mary Hulihan, Health Scientist, Centers for Disease Control and Prevention

Caroline E. Freiermuth, Associate Professor of Clinical Emergency Medicine, University of Cincinnati College of Medicine

Ruchi Doshi, Hospital Medicine Specialist and Assistant Professor of Medicine, Duke University

Titilope Fasipe, Assistant Professor of Pediatrics and Co-Director, Sickle Cell Program, Baylor College of Medicine

Q & A with Panelists
3:45–3:55 Summary Statements
3:55–4:00 Closing Remarks
Paul Volberding, Committee Chair
Jennifer Koop, Committee Vice Chair

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Friday, February 7, 2025 (1:00–4:00 PM ET)
WEBINAR 2: Pain Management and Sickle Cell Disease (SCD)

1:00–1:10 Welcome Remarks and Introductions
Paul Volberding, Committee Chair
Jennifer Koop, Committee Vice Chair
1:10–2:15 Session I: Living with and Managing Pain in SCD
Moderator
Shirley Johnson, Committee Member
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
Panelists
Teanika Hoffman, Sickle Cell Coalition of Maryland
Carolyn Rowley, Cayenne Wellness Center
Q & A with Panelists
2:15–2:30 Break
2:30–3:45 Session II: Pain Management in SCD
Moderators
Trish Kavanagh, Committee Member
Martha Kenney, Committee Member
Mechanisms of Pain Presentation
Daniel Sop, Virginia Commonwealth University
Panelists
Amanda Brandow, Medical College of Wisconsin
Pat Carroll, Johns Hopkins University
Wally Smith, Virginia Commonwealth University
Lara Zador, Henry Ford Health
Q & A with Panelists
3:45–3:55 Summary Statements
3:55–4:00 Closing Remarks
Paul Volberding, Committee Chair
Jennifer Koop, Committee Vice Chair

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Friday, February 21, 2025 (10:00 AM–1:00 PM ET)
WEBINAR 3: Functional Outcomes of Sickle Cell Disease (SCD)— The Whole-Person Experience

10:00–10:05 Welcome Remarks and Introductions
Jennifer Koop, Committee Vice Chair
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
10:05–11:15 Session I: Functional Outcomes in SCD
Moderator
Cece Calhoun, Committee Member
Panelists
Payal Desai, Atrium Health
Kelly Harris, Washington University in St. Louis

Eboni Lance, Kennedy Krieger Institute/Johns Hopkins University

Lakeya McGill, University of Pittsburgh

Jean Leclerc Raphael, Texas Children’s/Baylor College of Medicine

Q & A with Panelists
11:15–11:30 Break
11:30–12:45 Session II: SCD and Daily Life: Lived Experience
Moderator
Jerlym Porter, Committee Member
Panelists
Omini Ewah, OBIA Naturals; SCD Warrior
Golda Houndoh, PCORI; SCD Warrior
Vesha Jamison, American Red Cross; Caretaker
Q & A with Panelists
12:45–12:55 Summary Statements
12:55–1:00 Closing Remarks
Jennifer Koop, Committee Vice Chair
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.

This page intentionally left blank.

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
Page 115
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
Page 116
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
Page 117
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
Page 118
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
Page 119
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Washington, DC: The National Academies Press. doi: 10.17226/29137.
Page 120
Next Chapter: Appendix B: Biographical Sketches of Committee Members
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.